Education
Massachusetts Institute of Technology. Cornell University.
biologist executive president chief
Massachusetts Institute of Technology. Cornell University.
Doctor Rose has spent over two decades working with leading scientists and clinicians to create substantial commercial value from inventions based on genome technology. He is President of Rose Ventures Incorporated., a firm that provides consulting and directing to select clients in the life science research products space, and manages a portfolio of public and private equity investments. Doctor Rose is Chairman of Nabsys, a life sciences company pioneering development of semiconductor-based tools for genome analysis.
He is a Director of Invenra, a company developing novel technology for peptide drug discovery.
He serves as Chief Business Advisor for SerumDPT Bioscience, who are developing the first device enabling real-time isolation of plasma from drawn blood without centrifuging. Highlights from his 25+ year career in the genomics research products business include serving as Chief Executive Officer of NimbleGen Systems, Incorporated., a microarray products company, from 2003 through its acquisition by Roche for $272.5 million in 2007.
Company-founding and growing Genetic MicroSystems, a microarray instrumentation company that was acquired by Affymetrix for $280 million in 2000. And directing the polymerase chain reaction business for Perkin-Elmer and Applied Biosystems during its most dynamic growth phase in the 1990s.
Doctor Rose was a Director of Cellular Dynamics International, acquired by FujiFilm in 2015, and Chair of the Market Advisory Board for Cyvek, acquired by Biology-Techne in 2014.
Doctor Rose received his Bachelor of Arts from Cornell University and his Doctor of Philosophy from the Massachusetts Institute of Technology.
He is also a member of the Executive Board of Solving Organ Shortage, a non-profit foundation whose mission is to promote a unifying vision to solve the organ shortage through close scientific collaboration and inspired public policy.
